If you`re
attending the BIO
International Convention in Washington, DC on June 27-30th
here are some of the sessions covering issues in biotech patenting and
technology transfer:
Drug Patent
Linkage and Compulsory Licensing – Challenges of Working Patented Inventions in
India for Pharma Sector Monday, June 27, 2:00 pm – 3:15 pm.
The session deals with hot and highly debated topics -Patented drug regulatory
approval (BMS vs Hetero &Bayer Vs UOI 2010), Patent vs. pricing debate (Roche
vs Cipla), Compulsory Licensing: Export of patented drugs (Pfizer/ Roche vs
Natco), Linkages in Indian Patent System (Custom enforcement,
Biopharmaceuticals, Marketing –Approval and EMR, Efficacy testing, Competition,
Working).
IP Issues
Affecting Biomarker-Based Diagnostics. Monday, June 27,
3:45-5pm, Speakers will discuss challenges for securing IP protection for
biomarker diagnostics and discuss important cases before the Federal Circuit.
Patents in
the Supreme Court. Tuesday, June 28, 10-11:30am. Several
of the country`s most experienced Supreme Court litigators, among them former
Solicitor General of the United States, will discuss the direction of patent
law in the nation`s highest court and its implications for the biotechnology
industry.
Counterfeiting
– How Corporations and the Government Can Work Together.
Tuesday, June 28, 2:00-3:30pm. A panel of experts representing BIO
companies, government, and law enforcement will address the role of each entity
in identifying, arresting, and prosecuting counterfeiters. Victoria Espinel,
the first U.S. IP Enforcement Coordinator, will serve on the panel.
Navigating
the New Law on Licensing Biosimilars. Tuesday, June 28,
3:45-5pm. This panel discussion will address FDA`s structure and approach
to biosimilar reviews and guidance, the meaning of terms such as “highly
similar” and “interchangeability,” whether the new pathway may be used for
products presenting advances over existing products (“biobetters”), and the
complex and fast-moving patent dispute framework incorporated into the new law.
Technology
Transfer: New Methods, New Media, New Models for Improving Interactions with
Industry. Wednesday, June 29, 8:30-9:45am. With
increased pressure to do more with less resources, business development as well
as technology transfer offices have the task of efficiently moving inventions
and research materials through product development and ultimately into the
hands of consumers. This session will focus on traditional and new methods in
streamlining internal processes and technologies to accomplish this goal.
IP Challenges
for Personalized Medicine: Navigating Bilski,
Myriad, and Prometheus. Wednesday, June 29,
2-3:30pm. This session will outline the intersection of personalized
medicine and gene patents and will highlight how current cases, e.g., Bilski, Myriad and
Prometheus,
are affecting biotechnology. The session will also explore how companies can
deliver on the promise of personalized medicine in such an environment.
European
patent and unitary EU patent: the changes ahead. Thursday, June 30,
10-11:30am. This session will focus on the recent and expected changes in
EU, national and EPO laws and try to determine their impact on patenting, licensing
and global business development strategies.